Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Study On Mixing Covaxin, Covishield Gets Drug Regulator Approval: Sources

Study On Mixing Covaxin, Covishield Gets Drug Regulator Approval: Sources

NDTV
Wednesday, August 11, 2021 02:52:42 AM UTC

The study and its clinical trials, sources add, will be conducted by Vellore's Christian Medical College.

A study on mixing the combination of Covishield and Covaxin, the two main vaccines of the COVID-19 vaccination programme, has been given the go ahead by the Drugs Controller General Of India, say sources. This study and its clinical trials, sources add, will be conducted by Vellore's Christian Medical College. A Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had recommended conducting this study on July 29. This study will be different form the one undertaken by the Indian Council of Medical Research (ICMR) that revealed that mixing the two Covid vaccines elicited better safety and immunogenicity results.
Read full story on NDTV
Share this story on:-
More Related News
© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us